Video

Dr. Presant on Adjusting Clinical Trials to Value-Based Care

Cary Presant, MD, FACP, FASCO, City of Hope Medical Center, discusses clinical trials and value-based care.

Cary Presant, MD, FACP, FASCO, City of Hope Medical Center, discusses how clinical trials can be changed to better align with value-based care.

Currently, there is a trend toward changing care from volume-based to value-based. Clinical trials are not value-based, what with the expenses: more testing, more evaluations, more interactions with the clinical trial team and more resources used.

To adjust for that, there are strategies that can create more value-based clinical trials. Choosing trials carefully, keeping an adequate team caring for the patient throughout the trial process, using resources efficiently, and ensuring buy-in from the entire team can help to adjust the trial system. Adjusting clinical trials currently is necessary as the reliance of value-based care becomes more acute in the future.

Related Videos
Paolo Caimi, MD
Jennifer Scalici, MD
Steven H. Lin, MD, PhD
Anna Weiss, MD, associate professor, Department of Surgery, Oncology, associate professor, Cancer Center, University of Rochester Medicine
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Hematology/Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine
Victor Moreno, MD, PhD
Benjamin P. Levy, MD, with Kristie Kahl and Andrew Svonavec
Binod Dhakal, MD
Jill Corre, PharmD, PhD
Saad Z. Usmani, MD, MBA, FACP, FASCO